Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AXT, Inc. Announces Preliminary First Quarter 2024 Revenue Results and Schedules Earnings Release for May 2, 2024
-
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
-
Households May Finally Be Adjusting to Higher Mortgage Rates
-
Mountain Valley MD Announces Stock Option Grant
-
Mastek Earns 2024 Great Place To Work® Certification
-
LifeRoc Capital Informs Life Insurance Policy Owners That They May Now Leverage "The Tax Cuts and Jobs Act" to Enhance Life Settlement Benefits
-
Indian River State College Modernizes Technology Systems with Selection of Ellucian Banner SaaS
-
Blue Earth Therapeutics Announces Promising Results from Preclinical Evaluation of Synergistic Drug Combinations with Radiopharmaceutical ¹⁷⁷Lu-rhPSMA-10.1 for Treatment of Prostate Cancer
-
RXO Expands Responsible Care® Certification
-
Confluent to Announce First Quarter 2024 Financial Results on May 07, 2024
-
RenovoRx Announces $11.1 Million at Market Private Placement
-
KULR Technology Group Expands SafeCASE Application to Transform Battery Storage in eVTOL Manufacturing
-
Cintas Launches Search for 2024 America’s Best Restroom®
-
Orion Resource Partners sells further minority stake in Sweetwater Royalties
-
AudioEye Sets First Quarter 2024 Earnings Call
-
AGI First Quarter 2024 Results Release Date and Conference Call
-
electroCore Announces the Launch of Truvaga Plus® for General Wellness
-
Maybacks Global Partners with WiseDV in Launching iDreamCTV: A Next-Generation Streaming Platform
-
Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
-
Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
-
Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker
-
Alarum Estimates Record Quarterly Revenue of More Than $8.3 Million and All Time High Operating Cashflow of $3.2 Million for the First Quarter of 2024
-
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
-
TRILLION ENERGY PROVIDES OPERATIONAL UPDATE
-
Mullen Streamlines Business Operations to Focus on Near Term Commercial Opportunities
-
John F. Murphy joins Roper Technologies Board of Directors
-
Skyward Specialty to Host First Quarter 2024 Earnings Call Thursday, May 2, 2024
-
Apollo Commercial Real Estate Finance, Inc. Announces Dates for First Quarter 2024 Earnings Release and Conference Call
-
Cargotec corporation: Notice to Annual General Meeting 2024
-
Premier Transportation Appoints Tim Pilato to Co-CEO
-
Mapping The Future: Wavemaker China and YOYI TECH Unveil MarTech and AI Landscape
-
Applegate Farms LLC Announces $50,000 Support American Farmland Trust's Brighter Future Fund
-
Canadian Investment Regulatory Organization Trading Halt - ALY
-
TASEKO ANNOUNCES OFFERING OF US$500 MILLION OF SENIOR SECURED NOTES DUE 2030
-
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
-
McDonald's Netherlands uses scent for their latest campaign
-
New Growth in the 5G Millimeter Wave Market
-
North Highland Welcomes Monesia Taylor Brown
-
Morphy Auctions To Entertain With Rare Antique Coin-Ops, Advertising Signs, Apr. 11-13 In Las Vegas
-
The India Fund, Inc. Announces Rights Offering
-
Ferrari N.V.: Periodic Report on the Buyback Program
-
InterOcean Capital to Join The Colony Group
-
ENGIE ENERGÍA CHILE S.A. LAUNCHES TENDER OFFER FOR ANY AND ALL OF ITS 4.500% NOTES DUE 2025
-
Alliance Trust PLC - Net Asset Value
-
Canadian Investment Regulatory Organization Trading Halt - IBT
-
AMAG Technology offers Employee Badge in Apple Wallet for Symmetry Access Control Users
-
MDA SPACE DEFINES THE NEXT GENERATION OF ROBOTICS WITH NEW MDA SKYMAKER™ PRODUCT LINE
-
i-Health, Inc. Urges U.S. Congressional Leaders to Prioritize the Funding of Natural & Non-Hormonal Solutions for Menopause in Women's Health Research
-
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
-
Coya Therapeutics Scientific Advisory Board Chairman Dr. Stanley Appel to Present Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
